Key result
This comprehensive review evaluates the clinical relevance of high-sensitivity C-reactive protein as a marker of cardiovascular risk, with an emphasis on the JUPITER trial.
Why the study?
Does high-sensitivity C-reactive protein (hs-CRP) measurement improve cardiovascular risk assessment?
Design
Review
Authors
Loading...
May refine primary prevention risk stratification; leaves open prospective validation beyond JUPITER.
This review discusses the clinical relevance of hs-CRP as a cardiovascular risk marker, particularly in the context of the JUPITER trial.
Bajpai et al. (2010) conducted a review in Cardiovascular risk. High-sensitivity C-reactive protein (hs-CRP) measurement was evaluated. This comprehensive review evaluates the clinical relevance of high-sensitivity C-reactive protein as a marker of cardiovascular risk, with an emphasis on the JUPITER trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: